GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Supernus Pharmaceuticals SUPN · USD

Health Care · US listing · 🇺🇸 United States

Compare

27.62

+5.58%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Supernus Pharmaceuticals and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Supernus Pharmaceuticals SUPN 27.62$1.58bn—-5.4%— +5.58%
Integer Holdings ITGR 126.56$4.50bn43.85.6%— 0.00%
Tarsus Pharmaceuticals TARS 70.84$2.96bn—-14.7%— +3.27%
Viridian Therapeutics VRDN 30.19$2.88bn—-483.6%— +5.97%
Twist Bioscience TWST 135.34$8.09bn—-20.6%— +12.05%
Concentra Group Holdings Parent CON 42.40$5.43bn16.28.8%0.58% +0.43%
Structure Therapeutics Inc. American Depositary Shares GPCR 21.41$1.52bn——— +5.21%
Hinge Health HNGE 122.19$6.67bn—-89.9%— +5.55%
Privia Health Group PRVA 24.54$3.02bn92.71.1%— +0.49%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.